The Cooper Companies, Inc.
COO
Pozycja w akcjach
#1913
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Cena akcji
$58.13
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$11.05B
Zmiana (1 dzień)
0.33%
Zmiana (1 rok)
-22.48%
Kraj
US
Handel The Cooper Companies, Inc. (COO)
Kategoria
Healthcare
Zyski dla The Cooper Companies, Inc. (COO)
Zyski w Jul 2026 TTM: $462.40M
Według najnowszych raportów finansowych The Cooper Companies, Inc., obecny zysk firmy wynosi $462.40M. W roku 2024 firma osiągnęła zysk w wysokości $582.30M, wzrost w porównaniu do zysku z roku 2023, który wynosił $412.90M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy The Cooper Companies, Inc. od 2000 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $462.40M | -18.38% |
| 2025 | $566.50M | -2.71% |
| 2024 | $582.30M | 41.03% |
| 2023 | $412.90M | -13.13% |
| 2022 | $475.30M | -3.30% |
| 2021 | $491.50M | 84.43% |
| 2020 | $266.50M | -44.18% |
| 2019 | $477.40M | 43.84% |
| 2018 | $331.90M | -15.76% |
| 2017 | $394.00M | 33.27% |
| 2016 | $295.63M | 37.19% |
| 2015 | $215.49M | -27.33% |
| 2014 | $296.53M | -5.04% |
| 2013 | $312.27M | 13.37% |
| 2012 | $275.45M | 42.90% |
| 2011 | $192.76M | 54.92% |
| 2010 | $124.43M | 8.36% |
| 2009 | $114.83M | 50.68% |
| 2008 | $76.21M | 11,240.33% |
| 2007 | $672.00K | -99.08% |
| 2006 | $73.34M | -32.38% |
| 2005 | $108.46M | -3.58% |
| 2004 | $112.49M | 24.32% |
| 2003 | $90.49M | 38.85% |
| 2002 | $65.17M | 25.02% |
| 2001 | $52.13M | 23.74% |
| 2000 | $42.13M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $3.81B | 723.05% |
US
|
|
| $4.11B | 788.59% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 243.86% |
US
|
|
| - | - |
CH
|
